Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05161429Unknown

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Role: collaborator

NCT02519790Completed

Optimizing Medication Management for Mothers With Depression

Role: collaborator

NCT02508948Completed

Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study

Role: collaborator

All 3 trials loaded